NSN 6505-01-104-6393

Usp Cefoxitin For Injection

FSC: 6505     NIIN: 011046393

DODParts.com distributes drugs and biologicals, aircraft parts and consumables, electrical parts, fittings and other components for the aerospace and defense industries. Submit the short price quote form for NSN 6505-01-104-6393 to receive an up to date pricing and availability quote by email.

Product Characteristics

NSN:
6505011046393
Demilitarization:
NO
INC:
66663
Shelf Life:
24 mo.
Physical Form:
Powder
Active Medicament Medicinal Strength:
2.000 grams cefoxitin equivalent
Primary Container Type:
Vial
Primary Container Content Quantity:
2.000 grams of active ingredient
Total Primary Container Quantity:
25
Administration:
Intramuscular or intravenous
Part Name Assigned By Controlling Agency:
Cefoxitin sodium sterile usp 2gm vial 25s
Special Features:
20 ml. Size vial

Demand History (Solicitations)

Solicitation Qty End Date Purchase Request Small Business
SPE2DP18T0595 1 01/29/2018 0072590654 0%

Part Numbers

  • 304225
    FRESENIUS KABI USA, LLC
  • NDC00143-9877-25
    WEST-WARD PHARMACEUTICALS CORP.
  • NDC44567-0246-25
    WG CRITICAL CARE, LLC
  • NDC63323-0342-20
    FRESENIUS KABI USA, LLC
  • NDC63323-0342-25
    AMERICAN PHARMACEUTICAL PARTNERS

Shipping & Handling

HMIRS:

No information in HMIRS. Hazardous material unknown.

ESD:

No known electrostatic discharge.

Schedule B:

3004909185 - Medicaments primarily affecting the eyes, ears or respiratory system, put up in measured doses or in forms or packings for retail sale, nesoi.

Professional Distribution

  •   ITAR Registered
  •   DDTC Registered
  •   HAZMAT Certified
  •   AS9120 Quality Standards
  •   100% Quality Inspections
ITAR registered supplier

Need current pricing? Get a quote

Receive an official quote via email with pricing, availability, condition, and certifications when you submit this form below.

Qty:
Email Address:

NSN: 6505-01-104-6393 cefoxitin for injection,usp
Your Name:
Phone Number:
Company:
Privacy Policy    Order Terms
McAfee Secure